Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Study to Evaluate the Safety and Efficacy of Collagenase Clostridium Histolyticum (AA4500) in the Treatment of Lipoma

NCT02249052 is registered in ClinicalTrials.gov with Gerut, Zachary, M.D. as lead sponsor.

NCT NCT02249052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02249052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Study to Evaluate the Safety and Efficacy of Collagenase Clostridium Histolyticum (AA4500) in the Treatment of Lipoma
Lead sponsor
Gerut, Zachary, M.D.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2014
Completion date
June 30, 2016
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lipoma